Atrium Innovations names Peter Luther President and CEO

Former President of Johnson & Johnson Consumer Healthcare to lead Atrium\'s accelerated expansion

Atrium Innovations, a leader in the development, manufacturing and commercialisation of innovative, science-based natural health products, has named Peter Luther, former President of Johnson & Johnson Consumer Healthcare, as President and Chief Executive Officer of Atrium, effective at the end of June. He succeeds Pierre Fitzgibbon, who will leave the company by mutual agreement with the Board of Directors.

The company also announced that Jacques Bougie, former President and CEO of Alcan, W. Brian Edwards, founder and former CEO of BCE Emergis, and Luther will join Atrium's Board of Directors. Bougie will serve as Chairman of the Board and be based in Montreal, Québec, Canada.

Luther has 25 years of experience in the consumer packaged goods and healthcare industries. Since 1987, he has worked for Johnson & Johnson and has served as President of several of the company's large divisions over the past 10+ years. His most recent role was President of the Consumer Healthcare business.

“I'm honoured to have been selected to serve as Atrium's next CEO and am excited by the potential of this impressive company,” said Luther. “I see tremendous opportunities to build on Atrium's product portfolio and advance commercialisation and global distribution while upholding the company's unwavering commitment to high quality products that improve people's lives.”

Bougie was the President and CEO of Alcan, a Québec-based global aluminium producer and packaging products supplier, from 1993 to 2001. In this role, he spearheaded the greatest expansion in the company's history through its acquisition of AluSuisse in 2000 and laid the groundwork for the acquisition of the French group Péchiney in 2004. Before serving as CEO, he was President and COO of Alcan from 1989 to 1993.

Edwards is the founder and former CEO of BCE Emergis, one of North America's most successful electronic commerce companies. Under his leadership from 1988 to 2002, the company grew from a small start-up to a company with revenues of more than $650m and more than 2,000 employees.

You may also like

Finance

Nestlé extends consumer healthcare portfolio by agreeing to acquire Atrium Innovations

The transaction is expected to close in the first quarter of 2018 following the completion of customary approvals and closing conditions
Ingredients

Anthocyanin nanoencapsulation boosts the nutraceutical's absorbency in the gut, study reveals

Nanoencapsulation has been shown to prevent the premature degradation of anthocyanins in the gut, while also enhancing its bioavailability and efficacy as an anti-inflammatory and antioxidant
Ingredients

Certain supplement combinations could pose a risk to consumer health, experts warn

Certain functional ingredient combinations are associated with increased health risks, including arterial calcification, nutritional deficiencies, blood thinning and serotonin syndrome
Ingredients

Tate & Lyle debuts mouthfeel trend report for better food and beverage formulation

The company highlights the top nine most popular trends in food and beverage formulation, including hyper-crunch, mouthfeel mimicry and climate-proof food
Packaging

SIG debuts the world's first long-life probiotic buttermilk and secures 13 filling line sale

At Gulfood Manufacturing, SIG introduced its long-life, shelf-stable functional probiotic buttermilk, while also selling 13 filling lines to F&B manufacturers
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Study reveals astaxanthin's cardiovascular health-boosting potential in firefighters

AstaReal's Astaxanthin nutraceutical has been shown to elevate biomarkers of heart health at a dose of 12mg per day, while also mediating inflammation associated with high-intensity, short-duration exercise
Training & Education

dsm-firmenich awards Nutrition Research Grants totalling €250,000 to APAC-based gut health researchers

The nutrition-focused company will award up to €50,000 to each recipient to advance research on pre-, pro- and postbiotics, as well as human milk oligosaccharides (HMOs) on gut health and overall wellness
Subscribe now